EXAS icon

Exact Sciences

61.29 USD
+0.71
1.17%
At close Updated Oct 16, 4:00 PM EDT
Pre-market
After hours
61.04
--0.25
0.41%
1 day
1.17%
5 days
2.84%
1 month
15.77%
3 months
14.2%
6 months
45.03%
Year to date
7.66%
1 year
-13.21%
5 years
-40.68%
10 years
667.08%
 

About: Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Employees: 7,000

0
Funds holding %
of 7,495 funds
0
Analysts bullish %
of 7 analysts
0
Positive news %
of 13 articles
Price charts implemented using Lightweight Charts™